Analysts expect over 2019 decreasing revenue Carl Zeiss Meditec

Tomorrow the German company Carl Zeiss Meditec will publish its past quarters results. For this year Carl Zeiss Meditec's revenue will be around 1,44 billion euros. This is according to the average of the analysts' estimates. This is slightly lower than 2018's revenue of 1,46 billion euros.

Historical revenues and results Carl Zeiss Meditec plus estimates 2019

The analysts expect for 2019 a net profit of 174 million euros. The majority of the analysts expects for this year a profit per share of 1,94 euros. So the price/earnings-ratio equals a very huge 56,49.

Per share the analysts expect a dividend of 0,66 cents per share. Carl Zeiss Meditec's dividend yield thus equals 0,6 percent. The average dividend yield of the pharmaceutical companies is a low 1 percent.

Carl Zeiss Meditec's market capitalization is based on the number of outstanding shares around 9,8 billion euros. The Carl Zeiss Meditec stock was the past 12 months quite volatile. Since last December the stock is even 66 percent higher. This year the stock price moved between 65 and 113 euro.

Historical stock prices Carl Zeiss Meditec past 10 years

Click here for dividend . At 10.54 the stock trades 0,46 percent higher at 109,6 euros.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.